| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9840 | 
      | Human Intestinal Absorption | HIA+ | 0.5556 | 
      | Caco-2 Permeability | Caco2- | 0.7549 | 
      | P-glycoprotein Substrate | Substrate | 0.7587 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8753 | 
                                                     | Inhibitor | 0.6389 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8645 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.3858 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8729 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8183 | 
      | CYP450 3A4 Substrate | Substrate | 0.5350 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7905 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8017 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8895 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7558 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7875 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9144 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9764 | 
                                                                    | Non-inhibitor | 0.8162 | 
      | AMES Toxicity | Non AMES toxic | 0.8249 | 
      | Carcinogens | Non-carcinogens | 0.8656 | 
      | Fish Toxicity | High FHMT | 0.9095 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9161 | 
      | Honey Bee Toxicity | Low HBT | 0.6130 | 
      | Biodegradation | Not ready biodegradable | 0.9863 | 
      | Acute Oral Toxicity | III | 0.5699 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5183 |